Use of PP2A phosphatase modulators in the treatment of mental disorders

Details for Australian Patent Application No. 2003255513 (hide)

Owner Serono Genetics Institute S.A.

Inventors Abderrahim, Hadi; Shaikh, Sanober; Cohen, Daniel; Blumenfeld, Marta; Grel, Pascale; Palicio-Barron, Marta; Chumakov, Ilya

Agent FB Rice

Pub. Number AU-B-2003255513

PCT Number PCT/EP03/50247

PCT Pub. Number WO2004/001068

Priority 60/391,359 25.06.02 US

Filing date 20 June 2003

Wipo publication date 6 January 2004

Acceptance publication date 26 July 2007

International Classifications

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

A61K 38/46 (2006.01) Medicinal preparations containing peptides

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C07K 19/00 (2006.01) Hybrid peptides

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

C12Q 1/42 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving phosphatase

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/15 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

G01N 33/573 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for enzymes or isoenzymes

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

6 November 2003 Complete Application Filed

  Priority application(s): 60/391,359 25.06.02 US

4 March 2004 Application Open to Public Inspection

  Published as AU-B-2003255513

26 July 2007 Application Accepted

  Published as AU-B-2003255513

22 November 2007 Standard Patent Sealed

15 January 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003255514-PHOTOVOLTAIC DEVICE

2003255512-COPLANAR DISCHARGE FACEPLATES FOR PLASMA DISPLAY PANEL PROVIDING ADAPTED SURFACE POTENTIAL DISTRIBUTION